nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2-metastatic breast cancer

dc.contributor.authorHamilton, E.P.
dc.contributor.authorCortes, J.
dc.contributor.authorOzyilkan, O.
dc.contributor.authorChen, S-C.
dc.contributor.authorPetrakova, K.
dc.contributor.authorManikhas, A.
dc.contributor.authorJerusalem, G.
dc.contributor.authorHegg, R.
dc.contributor.authorHuober, J.
dc.contributor.authorChapman, S.C.
dc.contributor.authorYang, Z.
dc.contributor.authorChen, Y.
dc.contributor.authorJohnston, E.L.
dc.contributor.authorMartin, M.
dc.contributor.orcID0000-0001-8825-4918en_US
dc.contributor.researcherIDAAD-2817-2021en_US
dc.date.accessioned2021-04-28T06:54:38Z
dc.date.available2021-04-28T06:54:38Z
dc.date.issued2020
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.endpageS348en_US
dc.identifier.issn0923-7534en_US
dc.identifier.startpageS348en_US
dc.identifier.urihttps://www.annalsofoncology.org/article/S0923-7534(20)40371-0/pdf
dc.identifier.urihttp://hdl.handle.net/11727/5788
dc.identifier.volume31en_US
dc.identifier.wos000573469100273en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.annonc.2020.08.375en_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlenextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2-metastatic breast canceren_US
dc.typeconferenceObjecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PIIS0923753420403710.pdf
Size:
143.01 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: